{
    "id": 2797,
    "fullName": "LATS2 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "LATS2 positive indicates the presence of the LATS2 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 26524,
        "geneSymbol": "LATS2",
        "terms": [
            "LATS2",
            "KPM"
        ]
    },
    "variant": "positive",
    "createDate": "12/19/2014",
    "updateDate": "08/23/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1500,
            "approvalStatus": "Preclinical",
            "evidenceType": "Emerging",
            "efficacyEvidence": "In a preclinical study, LATS1 and LATS2 was identified as HSP90 clients and treatment of tumor cell lines in vitro and ovarian cancer patients in a Phase II trial with HSP90 inhibitor Tanespimycin (17-AAG), resulted in depletion of LATS1 and LATS2, hence disrupting the LATS-MST2-YAP tumor suppressor pathway (PMID:20841485).",
            "molecularProfile": {
                "id": 2612,
                "profileName": "LATS2 positive"
            },
            "therapy": {
                "id": 934,
                "therapyName": "Tanespimycin",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 1422,
                    "pubMedId": 20841485,
                    "title": "Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20841485"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2612,
            "profileName": "LATS2 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}